Our Campus

Avanti Polar Lipids operates FDA inspected and approved facilities, which consist of a total of 80,000 sq/ft contained in ten buildings, and include the following facilities:

  • Research manufacturing
  • cGMP manufacturing
  • Adjuvants
  • Formulations
  • Analytical
  • Administration

Avanti’s facilities and range of services are well suited for lipids and hydrophobic small molecule API production from pre-clinical through phase III, and API commercial manufacturing for approved drug products.